Cowealth Medical China Co.,Ltd. (SHA:603122)
17.78
-0.02 (-0.11%)
Jan 30, 2026, 4:00 PM EST
Cowealth Medical China Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 187.4 | 260.84 | 197.89 | 326.86 | 146.6 | 247.07 |
Trading Asset Securities | 5.8 | - | - | 10 | - | - |
Cash & Short-Term Investments | 193.2 | 260.84 | 197.89 | 336.86 | 146.6 | 247.07 |
Cash Growth | 3.51% | 31.81% | -41.25% | 129.78% | -40.66% | -11.52% |
Accounts Receivable | 775.33 | 746.93 | 758.84 | 747.95 | 557.35 | 543.39 |
Other Receivables | 1.39 | 2.15 | 7.65 | 4.77 | 6.89 | 10.07 |
Receivables | 776.72 | 749.08 | 766.49 | 752.72 | 564.24 | 553.46 |
Inventory | 195.71 | 201.88 | 196.87 | 204.82 | 178.86 | 140.35 |
Prepaid Expenses | - | - | - | - | - | 0.07 |
Other Current Assets | 120.51 | 79.18 | 93.54 | 116.95 | 80.14 | 25.96 |
Total Current Assets | 1,286 | 1,291 | 1,255 | 1,411 | 969.85 | 966.91 |
Property, Plant & Equipment | 114.09 | 118.95 | 118.53 | 81.98 | 88.27 | 80.07 |
Other Intangible Assets | 6.91 | 7.48 | 7.89 | 1.81 | 0.94 | 1.1 |
Long-Term Deferred Tax Assets | 33.34 | 29.99 | 34.3 | 31.79 | 29.06 | 32.43 |
Long-Term Deferred Charges | 21.97 | 21.9 | 17.78 | 13.82 | 23.43 | 10.56 |
Other Long-Term Assets | 58.98 | 22.63 | 24 | 15.63 | 5.96 | 6.7 |
Total Assets | 1,521 | 1,494 | 1,461 | 1,559 | 1,121 | 1,099 |
Accounts Payable | 352.46 | 224.12 | 167.67 | 240.09 | 127.8 | 127.53 |
Accrued Expenses | 9.03 | 36.8 | 43.4 | 40.11 | 37.82 | 31.25 |
Short-Term Debt | 19.86 | 46.27 | 53.92 | 51.31 | 97.64 | 91.35 |
Current Portion of Long-Term Debt | 3.46 | 2.22 | 8.84 | 8.69 | 10.15 | 17.15 |
Current Portion of Leases | - | 1.34 | 2.51 | 3.44 | 3.41 | - |
Current Income Taxes Payable | 2.15 | 5.11 | 7.08 | 14.56 | 13.99 | 20.56 |
Current Unearned Revenue | 0.7 | 1.61 | 1.14 | 2.04 | 9.12 | 4.92 |
Other Current Liabilities | 23.24 | 1.24 | 1.16 | 1.32 | 1.67 | 77.57 |
Total Current Liabilities | 410.91 | 318.7 | 285.73 | 361.55 | 301.61 | 370.34 |
Long-Term Debt | 2.39 | - | 2.18 | 10.84 | 11.99 | 7.32 |
Long-Term Leases | 0.23 | 0.74 | 3.5 | 5.71 | 7.91 | - |
Other Long-Term Liabilities | - | - | 1.08 | 2.38 | 3.28 | 4.77 |
Total Liabilities | 413.53 | 319.44 | 292.49 | 380.49 | 324.78 | 382.43 |
Common Stock | 398.05 | 398.05 | 398.05 | 398.05 | 298.54 | 298.54 |
Additional Paid-In Capital | 596.74 | 596.62 | 596.65 | 596.65 | 336.1 | 335.77 |
Retained Earnings | 106.63 | 170.76 | 167.08 | 179.6 | 168.53 | 88.3 |
Comprehensive Income & Other | 4.21 | 6.03 | 5.02 | 3.44 | -7.33 | -5.59 |
Total Common Equity | 1,106 | 1,171 | 1,167 | 1,178 | 795.83 | 717.02 |
Minority Interest | 2.26 | 3.16 | 2.11 | 0.83 | -0.07 | - |
Shareholders' Equity | 1,108 | 1,175 | 1,169 | 1,179 | 795.77 | 717.02 |
Total Liabilities & Equity | 1,521 | 1,494 | 1,461 | 1,559 | 1,121 | 1,099 |
Total Debt | 25.94 | 50.57 | 70.96 | 80 | 131.1 | 115.82 |
Net Cash (Debt) | 167.25 | 210.28 | 126.93 | 256.86 | 15.5 | 131.24 |
Net Cash Growth | 106.92% | 65.66% | -50.58% | 1556.84% | -88.19% | -31.41% |
Net Cash Per Share | 0.40 | 0.53 | 0.32 | 0.68 | 0.05 | 0.43 |
Filing Date Shares Outstanding | 398.05 | 398.05 | 398.05 | 398.05 | 398.05 | 298.54 |
Total Common Shares Outstanding | 398.05 | 398.05 | 398.05 | 398.05 | 298.54 | 298.54 |
Working Capital | 875.22 | 972.28 | 969.07 | 1,050 | 668.24 | 596.58 |
Book Value Per Share | 2.78 | 2.94 | 2.93 | 2.96 | 2.67 | 2.40 |
Tangible Book Value | 1,099 | 1,164 | 1,159 | 1,176 | 794.89 | 715.92 |
Tangible Book Value Per Share | 2.76 | 2.92 | 2.91 | 2.95 | 2.66 | 2.40 |
Buildings | - | 127.69 | 122.07 | 80.07 | 78.78 | 72.07 |
Machinery | - | 57.95 | 67.42 | 83.41 | 86.82 | 90.35 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.